Selected research
Industry Research
Polymyxin B Sulfate API Industry Research Report 2026
Market perspective
The global Polymyxin B Sulfate API market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Polymyxin B Sulfate API is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Polymyxin B Sulfate API is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Polymyxin B Sulfate API is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Polymyxin B Sulfate API include Yancheng Youhua Pharmaceutical And Chemical Technology, Shandong Luxi Pharmaceutical, Jiangxi Nuclear Industry Reyphon Bio-Chemical, North China Pharmaceutical Huasheng, Hangzhou Zhongmei Huadong Pharmaceutical, Ganzhou Ruizhi Pharmaceutical, Xellia Pharmaceuticals Aps, Rochem International and Medisca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Polymyxin B Sulfate API market in terms of revenue (US$ million) and, where applicable, sales volume (t), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/t) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Polymyxin B Sulfate API Market by Company
Yancheng Youhua Pharmaceutical And Chemical Technology
Shandong Luxi Pharmaceutical
Jiangxi Nuclear Industry Reyphon Bio-Chemical
North China Pharmaceutical Huasheng
Hangzhou Zhongmei Huadong Pharmaceutical
Ganzhou Ruizhi Pharmaceutical
Xellia Pharmaceuticals Aps
Rochem International
Medisca
LGM Pharma
ChemWerth
Biotika As
Alp Pharm
Polymyxin B Sulfate API Segment by Type
Purity ≥99%
95%≤purity≤99%
Polymyxin B Sulfate API Segment by Application
Injection
Others
Polymyxin B Sulfate API Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymyxin B Sulfate API market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Polymyxin B Sulfate API and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymyxin B Sulfate API.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Polymyxin B Sulfate API manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Polymyxin B Sulfate API by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Polymyxin B Sulfate API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Purity ≥99%
- 95%≤purity≤99%
Applications
- Injection
- Others
Companies covered
- Yancheng Youhua Pharmaceutical And Chemical Technology
- Shandong Luxi Pharmaceutical
- Jiangxi Nuclear Industry Reyphon Bio-Chemical
- North China Pharmaceutical Huasheng
- Hangzhou Zhongmei Huadong Pharmaceutical
- Ganzhou Ruizhi Pharmaceutical
- Xellia Pharmaceuticals Aps
- Rochem International
- Medisca
- LGM Pharma
- ChemWerth
- Biotika As
- Alp Pharm
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Polymyxin B Sulfate API Market Size (2021-2032)
- 2.2.2 Global Polymyxin B Sulfate API Sales (2021-2032)
- 2.2.3 Global Polymyxin B Sulfate API Market Average Price (2021-2032)
- 2.3 Polymyxin B Sulfate API by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Purity ≥99%
- 2.3.3 95%≤purity≤99%
- 2.4 Polymyxin B Sulfate API by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Injection
- 2.4.3 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Polymyxin B Sulfate API Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Polymyxin B Sulfate API Sales (t) of Manufacturers (2021-2026)
- 3.3 Global Polymyxin B Sulfate API Revenue of Manufacturers (2021-2026)
- 3.4 Global Polymyxin B Sulfate API Average Price by Manufacturers (2021-2026)
- 3.5 Global Polymyxin B Sulfate API Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Polymyxin B Sulfate API, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Polymyxin B Sulfate API, Product Type & Application
- 3.8 Global Manufacturers of Polymyxin B Sulfate API, Established Date
- 3.9 Global Polymyxin B Sulfate API Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Yancheng Youhua Pharmaceutical And Chemical Technology
- 4.1.1 Yancheng Youhua Pharmaceutical And Chemical Technology Company Information
- 4.1.2 Yancheng Youhua Pharmaceutical And Chemical Technology Business Overview
- 4.1.3 Yancheng Youhua Pharmaceutical And Chemical Technology Polymyxin B Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Yancheng Youhua Pharmaceutical And Chemical Technology Polymyxin B Sulfate API Product Portfolio
- 4.1.5 Yancheng Youhua Pharmaceutical And Chemical Technology Recent Developments
- 4.2 Shandong Luxi Pharmaceutical
- 4.2.1 Shandong Luxi Pharmaceutical Company Information
- 4.2.2 Shandong Luxi Pharmaceutical Business Overview
- 4.2.3 Shandong Luxi Pharmaceutical Polymyxin B Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Shandong Luxi Pharmaceutical Polymyxin B Sulfate API Product Portfolio
- 4.2.5 Shandong Luxi Pharmaceutical Recent Developments
- 4.3 Jiangxi Nuclear Industry Reyphon Bio-Chemical
- 4.3.1 Jiangxi Nuclear Industry Reyphon Bio-Chemical Company Information
- 4.3.2 Jiangxi Nuclear Industry Reyphon Bio-Chemical Business Overview
- 4.3.3 Jiangxi Nuclear Industry Reyphon Bio-Chemical Polymyxin B Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Jiangxi Nuclear Industry Reyphon Bio-Chemical Polymyxin B Sulfate API Product Portfolio
- 4.3.5 Jiangxi Nuclear Industry Reyphon Bio-Chemical Recent Developments
- 4.4 North China Pharmaceutical Huasheng
- 4.4.1 North China Pharmaceutical Huasheng Company Information
- 4.4.2 North China Pharmaceutical Huasheng Business Overview
- 4.4.3 North China Pharmaceutical Huasheng Polymyxin B Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 North China Pharmaceutical Huasheng Polymyxin B Sulfate API Product Portfolio
- 4.4.5 North China Pharmaceutical Huasheng Recent Developments
- 4.5 Hangzhou Zhongmei Huadong Pharmaceutical
- 4.5.1 Hangzhou Zhongmei Huadong Pharmaceutical Company Information
- 4.5.2 Hangzhou Zhongmei Huadong Pharmaceutical Business Overview
- 4.5.3 Hangzhou Zhongmei Huadong Pharmaceutical Polymyxin B Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Hangzhou Zhongmei Huadong Pharmaceutical Polymyxin B Sulfate API Product Portfolio
- 4.5.5 Hangzhou Zhongmei Huadong Pharmaceutical Recent Developments
- 4.6 Ganzhou Ruizhi Pharmaceutical
- 4.6.1 Ganzhou Ruizhi Pharmaceutical Company Information
- 4.6.2 Ganzhou Ruizhi Pharmaceutical Business Overview
- 4.6.3 Ganzhou Ruizhi Pharmaceutical Polymyxin B Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Ganzhou Ruizhi Pharmaceutical Polymyxin B Sulfate API Product Portfolio
- 4.6.5 Ganzhou Ruizhi Pharmaceutical Recent Developments
- 4.7 Xellia Pharmaceuticals Aps
- 4.7.1 Xellia Pharmaceuticals Aps Company Information
- 4.7.2 Xellia Pharmaceuticals Aps Business Overview
- 4.7.3 Xellia Pharmaceuticals Aps Polymyxin B Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Xellia Pharmaceuticals Aps Polymyxin B Sulfate API Product Portfolio
- 4.7.5 Xellia Pharmaceuticals Aps Recent Developments
- 4.8 Rochem International
- 4.8.1 Rochem International Company Information
- 4.8.2 Rochem International Business Overview
- 4.8.3 Rochem International Polymyxin B Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Rochem International Polymyxin B Sulfate API Product Portfolio
- 4.8.5 Rochem International Recent Developments
- 4.9 Medisca
- 4.9.1 Medisca Company Information
- 4.9.2 Medisca Business Overview
- 4.9.3 Medisca Polymyxin B Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Medisca Polymyxin B Sulfate API Product Portfolio
- 4.9.5 Medisca Recent Developments
- 4.10 LGM Pharma
- 4.10.1 LGM Pharma Company Information
- 4.10.2 LGM Pharma Business Overview
- 4.10.3 LGM Pharma Polymyxin B Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 LGM Pharma Polymyxin B Sulfate API Product Portfolio
- 4.10.5 LGM Pharma Recent Developments
- 4.11 ChemWerth
- 4.11.1 ChemWerth Company Information
- 4.11.2 ChemWerth Business Overview
- 4.11.3 ChemWerth Polymyxin B Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 ChemWerth Polymyxin B Sulfate API Product Portfolio
- 4.11.5 ChemWerth Recent Developments
- 4.12 Biotika As
- 4.12.1 Biotika As Company Information
- 4.12.2 Biotika As Business Overview
- 4.12.3 Biotika As Polymyxin B Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Biotika As Polymyxin B Sulfate API Product Portfolio
- 4.12.5 Biotika As Recent Developments
- 4.13 Alp Pharm
- 4.13.1 Alp Pharm Company Information
- 4.13.2 Alp Pharm Business Overview
- 4.13.3 Alp Pharm Polymyxin B Sulfate API Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Alp Pharm Polymyxin B Sulfate API Product Portfolio
- 4.13.5 Alp Pharm Recent Developments
5 Global Polymyxin B Sulfate API Market Scenario by Region
- 5.1 Global Polymyxin B Sulfate API Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Polymyxin B Sulfate API Sales by Region: 2021-2032
- 5.2.1 Global Polymyxin B Sulfate API Sales by Region: 2021-2026
- 5.2.2 Global Polymyxin B Sulfate API Sales by Region: 2027-2032
- 5.3 Global Polymyxin B Sulfate API Revenue by Region: 2021-2032
- 5.3.1 Global Polymyxin B Sulfate API Revenue by Region: 2021-2026
- 5.3.2 Global Polymyxin B Sulfate API Revenue by Region: 2027-2032
- 5.4 North America Polymyxin B Sulfate API Market Facts & Figures by Country
- 5.4.1 North America Polymyxin B Sulfate API Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Polymyxin B Sulfate API Sales by Country (2021-2032)
- 5.4.3 North America Polymyxin B Sulfate API Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Polymyxin B Sulfate API Market Facts & Figures by Country
- 5.5.1 Europe Polymyxin B Sulfate API Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Polymyxin B Sulfate API Sales by Country (2021-2032)
- 5.5.3 Europe Polymyxin B Sulfate API Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Polymyxin B Sulfate API Market Facts & Figures by Country
- 5.6.1 Asia Pacific Polymyxin B Sulfate API Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Polymyxin B Sulfate API Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Polymyxin B Sulfate API Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Polymyxin B Sulfate API Market Facts & Figures by Country
- 5.7.1 South America Polymyxin B Sulfate API Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Polymyxin B Sulfate API Sales by Country (2021-2032)
- 5.7.3 South America Polymyxin B Sulfate API Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Polymyxin B Sulfate API Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Polymyxin B Sulfate API Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Polymyxin B Sulfate API Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Polymyxin B Sulfate API Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Polymyxin B Sulfate API Sales by Type (2021-2032)
- 6.1.1 Global Polymyxin B Sulfate API Sales by Type (2021-2032) & (t)
- 6.1.2 Global Polymyxin B Sulfate API Sales Market Share by Type (2021-2032)
- 6.2 Global Polymyxin B Sulfate API Revenue by Type (2021-2032)
- 6.2.1 Global Polymyxin B Sulfate API Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Polymyxin B Sulfate API Revenue Market Share by Type (2021-2032)
- 6.3 Global Polymyxin B Sulfate API Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Polymyxin B Sulfate API Sales by Application (2021-2032)
- 7.1.1 Global Polymyxin B Sulfate API Sales by Application (2021-2032) & (t)
- 7.1.2 Global Polymyxin B Sulfate API Sales Market Share by Application (2021-2032)
- 7.2 Global Polymyxin B Sulfate API Revenue by Application (2021-2032)
- 7.2.1 Global Polymyxin B Sulfate API Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Polymyxin B Sulfate API Revenue Market Share by Application (2021-2032)
- 7.3 Global Polymyxin B Sulfate API Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Polymyxin B Sulfate API Value Chain Analysis
- 8.1.1 Polymyxin B Sulfate API Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Polymyxin B Sulfate API Production Mode & Process
- 8.2 Polymyxin B Sulfate API Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Polymyxin B Sulfate API Distributors
- 8.2.3 Polymyxin B Sulfate API Customers
9 Global Polymyxin B Sulfate API Analyzing Market Dynamics
- 9.1 Polymyxin B Sulfate API Industry Trends
- 9.2 Polymyxin B Sulfate API Industry Drivers
- 9.3 Polymyxin B Sulfate API Industry Opportunities and Challenges
- 9.4 Polymyxin B Sulfate API Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst